Tenders Are Invited For Completion Of A Non-Exclusive Discount Contract According To Section 130A Paragraph ...

Work Detail

Completion Of A Non-Exclusive Discount Contract According To Section 130A Paragraph 8 Sgb V For Tacrolimus (Ret), Atc Code: L04ad02 For The Period From March 1St, 2024 To February 28Th, 2026. This Announcement Serves To Conclude Drug Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient(S) Mentioned Under Point Ii.1.1). This Does Not Involve The Awarding Of Public Contracts Within The Meaning Of Directive 2014/24/Eu Or Sections 97 Ff Gwb. Any Pharmaceutical Company Can Become A Contractual Partner In Accordance With Section 4 Paragraph 18 Amg. According To The Case Law Of The Ecj, Such Approval Procedures Are Not Necessarily Subject To Public Procurement Law, Since No Competition Takes Place Due To The Lack Of A Selection Decision. The Announcement Serves As An Invitation To Conclude Discount Agreements With Conditions That Apply Equally To All Contractual Partners And Are Not Subject To Discretion, Including The Determination Of The Discount. The Contract Is Concluded By Signing The Contract Documents And Submitting The Required Declarations, Which Can Be Requested From The Contact Point Named Under I.3).

Contact Information

Other Detail